DDX26B Activators would represent a class of chemical substances that specifically interact with and enhance the activity of the DDX26B protein. DDX26B is presumed to be a member of the DEAD-box protein family, which are putative RNA helicases known to be involved in various aspects of RNA metabolism, including transcription, splicing, ribosome assembly, and RNA decay. DEAD-box proteins typically utilize ATP to unwind RNA duplexes, an essential process for the proper functioning of RNA-related cellular activities. Activators of DDX26B, therefore, would likely function by increasing the RNA helicase activity of the protein. This could be achieved by facilitating ATP binding or hydrolysis, stabilizing the protein in a conformation that is more conducive to RNA binding or unwinding, or enhancing the interaction between DDX26B and its RNA substrates or other protein partners involved in RNA processing.
The identification and study of DDX26B Activators would involve comprehensive biochemical and biophysical approaches. Structural biology techniques such as X-ray crystallography or NMR spectroscopy could be employed to determine the three-dimensional structure of DDX26B, providing insights into potential binding sites for activators. This structural knowledge would guide the synthesis of small molecules that might fit into these sites and modulate the protein's activity. Once potential activators are synthesized, their effect on DDX26B activity would be measured using in vitro assays. These assays could monitor the helicase activity of DDX26B by observing the unwinding of RNA duplexes in the presence of ATP and potential activators. Additionally, the binding affinity and kinetics of these molecules with DDX26B could be evaluated using surface plasmon resonance or isothermal titration calorimetry. Through such rigorous scientific evaluation, a detailed understanding of how DDX26B Activators influence the function of this RNA helicase would be developed, illuminating their role in RNA metabolism.
SEE ALSO...
Items 1 to 10 of 11 total
Display:
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
Doxorubicin | 23214-92-8 | sc-280681 sc-280681A | 1 mg 5 mg | $176.00 $426.00 | 43 | |
As a chemotherapeutic agent known to induce DNA damage, doxorubicin might upregulate INTS6L expression as part of the DNA damage response. | ||||||
Cisplatin | 15663-27-1 | sc-200896 sc-200896A | 100 mg 500 mg | $138.00 $380.00 | 101 | |
Cisplatin causes DNA crosslinking and could stimulate INTS6L expression through activation of the DNA repair pathway. | ||||||
Etoposide (VP-16) | 33419-42-0 | sc-3512B sc-3512 sc-3512A | 10 mg 100 mg 500 mg | $51.00 $231.00 $523.00 | 63 | |
This topoisomerase II inhibitor can lead to DNA damage and potential upregulation of genes involved in the DNA damage response, such as INTS6L. | ||||||
L-Mimosine | 500-44-7 | sc-201536A sc-201536B sc-201536 sc-201536C | 25 mg 100 mg 500 mg 1 g | $36.00 $88.00 $220.00 $436.00 | 8 | |
Mimosine induces cell cycle arrest and may affect the expression of genes like INTS6L that are related to RNA processing. | ||||||
Hydroxyurea | 127-07-1 | sc-29061 sc-29061A | 5 g 25 g | $78.00 $260.00 | 18 | |
Hydroxyurea induces replication stress and could upregulate INTS6L expression as part of the cellular stress response. | ||||||
Camptothecin | 7689-03-4 | sc-200871 sc-200871A sc-200871B | 50 mg 250 mg 100 mg | $58.00 $186.00 $94.00 | 21 | |
As an inhibitor of topoisomerase I, camptothecin introduces DNA breaks, possibly influencing INTS6L expression. | ||||||
Chloroquine | 54-05-7 | sc-507304 | 250 mg | $69.00 | 2 | |
Chloroquine affects nucleic acid metabolism and could hypothetically alter the expression of INTS6L. | ||||||
Methotrexate | 59-05-2 | sc-3507 sc-3507A | 100 mg 500 mg | $94.00 $213.00 | 33 | |
Methotrexate impacts nucleotide biosynthesis and could modulate the expression of genes associated with RNA processing. | ||||||
Actinomycin D | 50-76-0 | sc-200906 sc-200906A sc-200906B sc-200906C sc-200906D | 5 mg 25 mg 100 mg 1 g 10 g | $74.00 $243.00 $731.00 $2572.00 $21848.00 | 53 | |
Known to inhibit transcription, actinomycin D might influence INTS6L expression by acting on RNA polymerase II. | ||||||
PMA | 16561-29-8 | sc-3576 sc-3576A sc-3576B sc-3576C sc-3576D | 1 mg 5 mg 10 mg 25 mg 100 mg | $41.00 $132.00 $214.00 $500.00 $948.00 | 119 | |
PMA activates protein kinase C and could alter gene expression profiles, which might affect INTS6L. | ||||||